Constat · Stage 3 · Payment

Trace FDA clearance to medical-device reimbursement.

Follow documented links from an FDA AI-device clearance to NTAP, CPT or HCPCS identifiers, CMS rates, MAC coverage, and public payer policies. See which mechanism is present, which amount and effective date were recorded, and where no dedicated pathway is documented.

Research method: separate coding, coverage, and payment

37
devices traced
40
payment pathways
12
payer policies indexed

Payment mechanisms — live corpus

Category III CPT / APC
15 pathways · median $651
15
$38–$996
cat_iii
13 pathways
13
NTAP add-on (inpatient)
6 pathways · median $969
6
$241–$1,868
Category I CPT + CMS rate
6 pathways · median $919
4
$40–$1,017

Mechanisms are reported separately, never pooled into one “reimbursement rate.” An NTAP add-on and an OPPS/APC rate are different measurements; each amount keeps its mechanism, setting, effective date, and source link. Bars compare device counts, not dollars. CPT codes appear as bare factual identifiers — follow the CMS link for the official descriptor.

Medical-device reimbursement strategy

Connect clearance, codes, coverage, and payment without collapsing them

What is a medical-device reimbursement strategy?

It is a source-backed plan for coding, coverage, payment, evidence, and market access. FDA clearance and reimbursement are separate decisions, so teams typically map the device to the relevant setting, coding pathway, payer policies, and evidence requirements.

Does FDA clearance mean that Medicare or a commercial payer will cover a device?

No. FDA authorization addresses marketing under the applicable regulatory pathway. Coding, coverage, and payment are separate processes, and coverage can vary by benefit, setting, payer, jurisdiction, policy, and evidence.

Which records can connect a medical device to reimbursement?

Depending on the pathway, useful public records can include CPT or HCPCS identifiers, NTAP decisions, CMS fee schedules and rates, MAC local coverage determinations, and public commercial-payer policies. Each amount must remain attached to its mechanism and effective date.

Constat reports documented pathways and source gaps; it does not provide coding, coverage, billing, or reimbursement advice.

Machine access

Query the same graph over MCP — reimbursement_lookup, reimbursement_search, reimbursement_stats
curl -s https://constat.dev/api/mcp \
  -H 'content-type: application/json' \
  -d '{"jsonrpc":"2.0","id":1,"method":"tools/call",
       "params":{"name":"reimbursement_search",
                 "arguments":{"mechanism":"ntap"}}}'

Look up by FDA clearance number or bare CPT code; every amount carries its mechanism, effective date, and a source link — descriptive only, never billing or coverage advice.

Need a clearance-to-payment evidence map for a device or category?

Share the clearance, product category, and market-access question. Health AI will scope a source-linked map of documented payment mechanisms, rates, coverage policies, evidence gaps, and limitations.

CPT is a registered trademark of the AMA; codes are shown as factual identifiers only. Public CMS/FDA data and payers’ own published policies.

Statistical pattern analysis of public FDA / CMS data — descriptive decision-support, not legal, regulatory, coding, or reimbursement advice. Verify against primary sources. A Health AI product · machine access over MCP · terms & dataset license.